| COVID-19 Vaccine |
1 |
1 |
| Vaccines |
0 |
0.9 |
| Immunization |
0 |
0.85 |
| Biologic Therapy |
0 |
0.7 |
| COVID-19 |
0 |
0.69 |
| Monoclonal Antibody |
0 |
0.52 |
| HIV Infection |
0 |
0.47 |
| Antineoplastic Drug |
0 |
0.41 |
| Immunocompromise |
0 |
0.31 |
| Social Distancing |
0 |
0.21 |
| Adolescent Medicine |
0 |
0.1 |
| Alabama |
0 |
0.1 |
| Arthritis |
0 |
0.1 |
| Clinical Guidelines |
0 |
0.1 |
| Glucocorticoid |
0 |
0.1 |
| Immunoglobulin G (IgG) |
0 |
0.1 |
| Interleukin |
0 |
0.1 |
| Jobs |
0 |
0.1 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.1 |
| Pandemic |
0 |
0.1 |
| Prophylaxis |
0 |
0.1 |
| Rheumatic Disease |
0 |
0.1 |
| Severe Acute Respiratory Syndrome |
0 |
0.1 |
| Tumor |
0 |
0.1 |
| Social Determinants of Health |
0 |
0.08 |
| Acute Respiratory Distress Syndrome |
0 |
0.04 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.04 |